Tuesday, 6 October 2026European Markets
ExploreSearch
ViaNews EU

EU Tech Regulation

2 articles

Anthropic sues Pentagon over supply chain ban as AI labs face military-commercial split

Anthropic sues Pentagon over supply chain ban as AI labs face military-commercial split

Anthropic filed suit against the US Department of Defense on March 9 over designation as a supply chain security risk, marking the first legal challenge by a major AI lab to national security restrictions. The lawsuit comes as Google agrees to provide AI agents to the Pentagon and OpenAI's hardware chief resigns following a defense contract, signaling a strategic divide in how AI companies handle government work.

ViaNews Editorial Team (Europe)•
EU Caught Between Open AI Access and US-China Tech Race as Governance Models Diverge

EU Caught Between Open AI Access and US-China Tech Race as Governance Models Diverge

Europe faces a strategic dilemma as AI governance fractures along geopolitical lines, with the Pentagon banning Anthropic's Claude and India joining US supply chains. French AI leader Arthur Mensch argues the real battle is open versus closed AI systems, not geography—a debate with direct implications for Europe's AI Act and competitive positioning.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com